Despite the success of antiretroviral therapy (ART) for people living with HIV, lifelong treatment
is required and there is no cure. HIV can integrate in the host genome and persist for the …

Background The level of evidence for HIV transmission risk through condomless sex in
serodifferent gay couples with the HIV-positive partner taking virally suppressive antiretroviral …

Since SARS-CoV-2 appeared in the human population, the scientific community has scrambled
to gather as much information as possible to find good strategies for the containment …

Viral rebound upon stopping combined antiretroviral therapy poses a major barrier toward
an HIV cure. Cellular and anatomical sources responsible for reinitiating viral replication …

Background Before April 2022, monkeypox virus infection in humans was seldom reported
outside African regions where it is endemic. Currently, cases are occurring worldwide. …

Despite scientific evidence originating from two patients published to date that CCR5Δ32/Δ32
hematopoietic stem cell transplantation (HSCT) can cure human immunodeficiency virus …

Background Effective two-drug regimens could decrease long-term drug exposure and toxicity
with HIV-1 antiretroviral therapy (ART). We therefore aimed to evaluate the efficacy and …

The insertion of a DNA copy of its RNA genome into a chromosome of the hostcell is mediated
by the viral integrase with the help of mostlyuncharacterized cellular cofactors. We have …

Background An appropriate normalization strategy is crucial for data analysis from real time
reverse transcription polymerase chain reactions (RT-qPCR). It is widely supported to …

Background Infections with SARS-CoV-2 continue to cause significant morbidity and mortality.
Interleukin (IL)-1 and IL-6 blockade have been proposed as therapeutic strategies in …